Last 160.25 INR
Change Today -4.95 / -3.00%
Volume 64.3K
CLAR On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:27 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

claris lifesciences ltd (CLAR) Snapshot

Open
166.70
Previous Close
165.20
Day High
167.00
Day Low
158.10
52 Week High
12/30/13 - 229.00
52 Week Low
06/2/14 - 141.25
Market Cap
8.7B
Average Volume 10 Days
167.3K
EPS TTM
13.23
Shares Outstanding
54.6M
EX-Date
01/20/14
P/E TM
12.1x
Dividend
9.00
Dividend Yield
5.62%
Current Stock Chart for CLARIS LIFESCIENCES LTD (CLAR)

Related News

No related news articles were found.

claris lifesciences ltd (CLAR) Related Businessweek News

No Related Businessweek News Found

claris lifesciences ltd (CLAR) Details

Claris Lifesciences Limited, together with its subsidiaries, operates as a sterile injectables pharmaceutical company worldwide. The company manufactures and markets products for anesthesia and analgesia; blood; anti-infectives, such as quinolone, beta lactum, anti-fungal, and aminoglycoside; and oncology segments. It also provides enteral nutrition products and delivery systems; and therapy, peritoneal dialysis products, and medicines for renal and transplant. In addition, the company offers injectables for various therapeutic groups, including anti-emetics, CNS, cardiology, anti-malaria, haematinics, etc in various delivery systems, such as glass bottles, vials, ampoules, and non-PVC/PVC bags. It serves government and private hospitals, aid agencies, and nursing homes. The company was incorporated in 1994 and is headquartered in Ahmedabad, India.

999 Employees
Last Reported Date: 05/23/14
Founded in 1994

claris lifesciences ltd (CLAR) Top Compensated Officers

Managing Director, Chief Executive Officer, W...
Total Annual Compensation: 15.0M
President of Finance, Whole Time Director, Me...
Total Annual Compensation: 4.7M
Vice President of Technical and Whole Time Di...
Total Annual Compensation: 4.7M
Compensation as of Fiscal Year 2013.

claris lifesciences ltd (CLAR) Key Developments

Claris Lifesciences Limited Appoints KPMG as Internal Auditors

Claris Lifesciences Limited announced that at the Board of Directors of the company at its meeting held on July 04, 2014 approved the appointment of M/s. KPMG as internal auditors of the company for the year 2014-15.

Claris Lifesciences Limited, Board Meeting, Jul 04, 2014

Claris Lifesciences Limited, Board Meeting, Jul 04, 2014. Agenda: To consider to transfer the company's specialty Injectable business by way of a slump sale to its wholly owned subsidiary, subject to necessary approval of the shareholders' through a postal ballot and as per the provisions of Section 180(1)(a) and other applicable provisions of the Companies Act, 2013; and to consider the appointment of M/s. KPMG as internal auditors of the company for the year 2014-15.

Claris Lifesciences Limited, Board Meeting, Jun 17, 2014

Claris Lifesciences Limited, Board Meeting, Jun 17, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLAR:IN 160.25 INR -4.95

CLAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLAR.
View Industry Companies
 

Industry Analysis

CLAR

Industry Average

Valuation CLAR Industry Range
Price/Earnings 12.8x
Price/Sales 1.7x
Price/Book 0.7x
Price/Cash Flow 7.7x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLARIS LIFESCIENCES LTD, please visit www.clarislifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.